During the COVID-19 pandemic, wastewater surveillance of infectious diseases gained traction across the United States to better target at risk communities. But the sampling can go much further, especially if wastewater systems collaborate with laboratories and public health officials.
Cameron Colby, national institute on drug abuse program manager for Biobot Analytics, explains what she and her team have learned by conducting this monitoring at wastewater utilities, and why it is important for utilities and their missions.
Additional Resources
- Read about wastewater epidemiology: https://www.waterworld.com/wastewater/treatment/article/14281682/something-in-the-wastewater
- Learn more about Biobot Analytics: https://biobot.io/
Timestamps
- Lessons in wastewater infectious diseasee monitoring | 0:00
- The value of monitoring for utiltiies | 1:58
- Influent vs. effluent sampling | 3:35
- The future of sewer epidemiology | 4:42
- Sharing information with public health officials | 6:30
Sign up for More Wastewater Digest Content
- Subscribe to Wastewater Digest: https://endeavor.dragonforms.com/loading.do?omedasite=WWD_new&pk=WWD_EdVid_NN
- Renew your Wastewater Digest subscription: https://endeavor.dragonforms.com/loading.do?omedasite=WWD_renew&pk=WWD_EdVid_RE
- Sign up to our newsletter: https://endeavor.dragonforms.com/loading.do?omedasite=WWDnewpref&pk=WWD_EdVid_ENL
Connect with WWD on Social Media
- Facebook: www.fb.com/waterwastesdigest
- Twitter: www.twitter.com/wwdmag
- LinkedIn: www.linkedin.com/company/waterwastesdigest
